Misplaced Pages

Suvizumab: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 23:11, 13 November 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'ChemSpiderID_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_...← Previous edit Latest revision as of 19:04, 6 May 2024 edit undoMarbletan (talk | contribs)Extended confirmed users5,489 editsNo edit summary 
(20 intermediate revisions by 14 users not shown)
Line 1: Line 1:
{{Short description|Monoclonal antibody}}
{{Drugbox {{Drugbox
| Verifiedfields = changed | Verifiedfields = changed
| verifiedrevid = 450329548 | verifiedrevid = 470475254
| type = mab | type = mab
| image = | image =
Line 8: Line 9:
| source = zu | source = zu
| target = ] | target = ]
<!--Clinical data--> <!--Clinical data -->
| tradename = | tradename =
| Drugs.com = | Drugs.com =
Line 15: Line 16:
| pregnancy_US = <!-- A / B / C / D / X --> | pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category= | pregnancy_category=
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM --> | legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
Line 21: Line 22:
| legal_status = | legal_status =
| routes_of_administration = | routes_of_administration =
<!-- Pharmacokinetic data -->

<!--Pharmacokinetic data-->
| bioavailability = | bioavailability =
| protein_bound = | protein_bound =
Line 28: Line 28:
| elimination_half-life = | elimination_half-life =
| excretion = | excretion =
<!-- Identifiers -->

<!--Identifiers-->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = NA | ChemSpiderID = none
| CAS_number_Ref = {{cascite|correct|??}} | CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 1116433-11-4 | CAS_number = 914257-21-9
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4AJ2TI6DPI
| ATC_prefix = none | ATC_prefix = none
| ATC_suffix = | ATC_suffix =
Line 39: Line 40:
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = | DrugBank =
<!-- Chemical data -->

<!--Chemical data-->
| chemical_formula = | chemical_formula =
| molecular_weight = | molecular_weight =
Line 46: Line 46:
}} }}


'''Suvizumab''' is an antiviral and immunomodulator. It binds to ].<ref>{{cite journal | author = ] | title = International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103 | journal = WHO Drug Information | year = 2010 | url = http://www.who.int/medicines/publications/druginformation/INN_PL103.pdf | format=PDF}}</ref> '''Suvizumab''' is an experimental ] and ]. It is a ] that binds to ].<ref>{{cite journal |title = Proposed List number 102 of International Nonproprietary Names|journal = WHO Drug Information|year = 2009|url =https://www.who.int/entity/medicines/publications/druginformation/innlists/PL_102.pdf|publisher = World Health Organization|location = Geneva|issn = 1010-9609|page = 344|volume = 23|issue = 4}}</ref>


== References == == References ==
Line 54: Line 54:


] ]
]


{{antiinfective-drug-stub}} {{antiinfective-drug-stub}}
{{monoclonal-antibody-stub}} {{monoclonal-antibody-stub}}

Latest revision as of 19:04, 6 May 2024

Monoclonal antibody Pharmaceutical compound
Suvizumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized
TargetHIV-1
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
  (what is this?)  (verify)

Suvizumab is an experimental antiviral drug and immunomodulator. It is a monoclonal antibody that binds to HIV-1.

References

  1. "Proposed List number 102 of International Nonproprietary Names" (PDF). WHO Drug Information. 23 (4). Geneva: World Health Organization: 344. 2009. ISSN 1010-9609.
Monoclonal antibodies for infectious disease and toxins
Fungal
Human
Viral
Human
Chimeric
Humanized
Bacterial
Human
Mouse
Chimeric
Humanized
Toxin
Human
Chimeric
Humanized
Stub icon

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

Categories: